Uhl et al. amplified the MYCN oncogene in two neuroblastoma cell lines and evaluated the effect of harmine, a tricyclic β-carboline alkaloid isolated from the harmal plant that acts as a MAO-A inhibitor. This evidence concerns the gene MYCN and neuroblastoma.